Tags

Type your tag names separated by a space and hit enter

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620963016.TA

Abstract

The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) in March 2020. According to clinical studies carried out in China and Italy, most patients experience mild or moderate symptoms; about a fifth of subjects develop a severe and critical disease, and may suffer from interstitial pneumonia, possibly associated with acute respiratory distress syndrome (ARDS) and death.In patients who develop respiratory failure, timely conventional oxygen therapy through nasal catheter plays a crucial role, but it can be used only in mild forms. Continuous positive airway pressure (CPAP) support or non-invasive mechanical ventilation (NIV) are uncomfortable, and require significant man-machine cooperation. Herein we describe our experience of five patients with COVID-19, who were treated with high-flow nasal cannula (HFNC) after failure of CPAP or NIV, and discuss the role of HFNC in COVID-19 patients. Our findings suggest that HFNC can be used successfully in selected patients with COVID-19-related ARDS.The reviews of this paper are available via the supplemental material section.

Authors+Show Affiliations

Infectious and Tropical Disease Unit, 'Magna Graecia' University, Viale Europa, Catanzaro, 88100, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Respiratory Disease Unit, 'Magna Graecia' University Hospital of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Respiratory Disease Unit, 'Magna Graecia' University Hospital of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.Department of Health Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy.

Pub Type(s)

Journal Article
Observational Study

Language

eng

PubMed ID

33070706

Citation

Procopio, Giada, et al. "Oxygen Therapy Via High Flow Nasal Cannula in Severe Respiratory Failure Caused By Sars-Cov-2 Infection: a Real-life Observational Study." Therapeutic Advances in Respiratory Disease, vol. 14, 2020, p. 1753466620963016.
Procopio G, Cancelliere A, Trecarichi EM, et al. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Ther Adv Respir Dis. 2020;14:1753466620963016.
Procopio, G., Cancelliere, A., Trecarichi, E. M., Mazzitelli, M., Arrighi, E., Perri, G., Serapide, F., Pelaia, C., Lio, E., Busceti, M. T., Pelle, M. C., Ricchio, M., Scaglione, V., Davoli, C., Fusco, P., La Gamba, V., Torti, C., & Pelaia, G. (2020). Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Therapeutic Advances in Respiratory Disease, 14, 1753466620963016. https://doi.org/10.1177/1753466620963016
Procopio G, et al. Oxygen Therapy Via High Flow Nasal Cannula in Severe Respiratory Failure Caused By Sars-Cov-2 Infection: a Real-life Observational Study. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. PubMed PMID: 33070706.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. AU - Procopio,Giada, AU - Cancelliere,Anna, AU - Trecarichi,Enrico Maria, AU - Mazzitelli,Maria, AU - Arrighi,Eugenio, AU - Perri,Graziella, AU - Serapide,Francesca, AU - Pelaia,Corrado, AU - Lio,Elena, AU - Busceti,Maria Teresa, AU - Pelle,Maria Chiara, AU - Ricchio,Marco, AU - Scaglione,Vincenzo, AU - Davoli,Chiara, AU - Fusco,Paolo, AU - La Gamba,Valentina, AU - Torti,Carlo, AU - Pelaia,Girolamo, PY - 2020/10/19/entrez PY - 2020/10/20/pubmed PY - 2020/10/31/medline KW - COVID-19 KW - SARS-CoV-2 KW - continuous positive airway pressure KW - high-flow nasal cannula KW - respiratory failure SP - 1753466620963016 EP - 1753466620963016 JF - Therapeutic advances in respiratory disease JO - Ther Adv Respir Dis VL - 14 N2 - The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the World Health Organization (WHO) in March 2020. According to clinical studies carried out in China and Italy, most patients experience mild or moderate symptoms; about a fifth of subjects develop a severe and critical disease, and may suffer from interstitial pneumonia, possibly associated with acute respiratory distress syndrome (ARDS) and death.In patients who develop respiratory failure, timely conventional oxygen therapy through nasal catheter plays a crucial role, but it can be used only in mild forms. Continuous positive airway pressure (CPAP) support or non-invasive mechanical ventilation (NIV) are uncomfortable, and require significant man-machine cooperation. Herein we describe our experience of five patients with COVID-19, who were treated with high-flow nasal cannula (HFNC) after failure of CPAP or NIV, and discuss the role of HFNC in COVID-19 patients. Our findings suggest that HFNC can be used successfully in selected patients with COVID-19-related ARDS.The reviews of this paper are available via the supplemental material section. SN - 1753-4666 UR - https://www.unboundmedicine.com/medline/citation/33070706/Oxygen_therapy_via_high_flow_nasal_cannula_in_severe_respiratory_failure_caused_by_Sars_Cov_2_infection:_a_real_life_observational_study_ L2 - https://journals.sagepub.com/doi/10.1177/1753466620963016?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -